<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00126334</url>
  </required_header>
  <id_info>
    <org_study_id>2003-003</org_study_id>
    <nct_id>NCT00126334</nct_id>
  </id_info>
  <brief_title>Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot</brief_title>
  <acronym>CRIT</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>US Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine whether a conservative or a liberal blood&#xD;
      transfusion strategy is better for patients with a heart attack and a low blood count.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current standard of care for patients with heart attacks is to transfuse red blood cells&#xD;
      when the hematocrit (red blood cell count) drops below 30 percent. However, there is little&#xD;
      scientific basis for this current standard, and recent research has demonstrated that it is&#xD;
      safe to allow the hematocrit (red blood cell count) to drop significantly lower in severely&#xD;
      ill medical patients and in patients with heart disease undergoing major surgery. The&#xD;
      investigators therefore propose this pilot trial to begin to determine whether or not it is&#xD;
      safe to apply a more conservative blood transfusion strategy to patients with heart attacks.&#xD;
&#xD;
      In this study, patients who are within 72 hours of the onset of a heart attack and who are&#xD;
      anemic (have a low red blood cell count) will be randomly assigned to one of two transfusion&#xD;
      strategies while they are in the hospital: a liberal strategy of transfusing blood when the&#xD;
      hematocrit falls below 30 percent (the current standard) or a conservative strategy of&#xD;
      transfusing blood only when the hematocrit falls below 24 percent. It will then be determined&#xD;
      which group fares better over the next 30 days.&#xD;
&#xD;
      The plan is to enroll 92 patients in this pilot trial in order to allow the researchers to&#xD;
      plan for a much larger, definitive trial of this important question. It is anticipated that&#xD;
      the conservative transfusion strategy will be similar to the standard (liberal) strategy in&#xD;
      terms of patient outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital death</measure>
    <time_frame>In-hospital</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrent myocardial infarction (MI)</measure>
    <time_frame>In-hospital</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>New or worsening heart failure</measure>
    <time_frame>In-hospital</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Critical Care Unit (CCU) length of stay</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death or recurrent MI at hospital discharge and 30 days</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death or recurrent MI or new or worsening congestive heart failure (CHF) at 30 days</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death at 30 days</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital recurrent ischemia</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital death or recurrent MI or new or worsening CHF or recurrent ischemia</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute renal insufficiency (increase in serum creatinine of â‰¥ 0.5mg/dL)</measure>
    <time_frame>In-hospitall</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of transfusions received per patient</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients receiving at least one transfusion</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean daily hematocrit</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion-related reactions</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liberal transfusion threshold</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conservative transfusion threshold</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Packed Red Blood Cell Transfusion</intervention_name>
    <description>transfusion of 1 unit of PRBCs</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All of the following must be present:&#xD;
&#xD;
          -  Acute myocardial infarction with presentation within 72 hours of randomization (acute&#xD;
             myocardial infarction is defined as ischemic-type chest discomfort lasting at least 30&#xD;
             minutes associated with creatinine kinase MB (CKMB) or troponin &gt;upper limit of normal&#xD;
             [ULN])&#xD;
&#xD;
          -  Admission to CCU&#xD;
&#xD;
          -  Hematocrit .30 or less&#xD;
&#xD;
          -  Written, informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability or unwillingness to receive red cell transfusions&#xD;
&#xD;
          -  Active bleeding (overt blood loss accompanied by a decrease in hematocrit of at least&#xD;
             5% in the preceding 12 hours)&#xD;
&#xD;
          -  Receipt of red cell transfusion within 7 days of randomization&#xD;
&#xD;
          -  Prior severe transfusion reaction&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Imminent death&#xD;
&#xD;
          -  Decision to provide limited care&#xD;
&#xD;
          -  Age &lt;21&#xD;
&#xD;
          -  Participation in another clinical trial in which blood transfusion is a requirement or&#xD;
             a component of a primary or secondary endpoint&#xD;
&#xD;
          -  Previous participation in the CRIT Pilot&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard A Cooper, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medstar Health Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington VA Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durham VA Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <study_first_submitted>August 2, 2005</study_first_submitted>
  <study_first_submitted_qc>August 2, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2005</study_first_posted>
  <last_update_submitted>July 20, 2011</last_update_submitted>
  <last_update_submitted_qc>July 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Neil Weissman</name_title>
    <organization>Medstar Research Institute</organization>
  </responsible_party>
  <keyword>Myocardial Infarction</keyword>
  <keyword>Anemia</keyword>
  <keyword>Erythrocyte Transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

